Zobrazeno 1 - 10
of 50
pro vyhledávání: '"Jennifer A Crozier"'
Autor:
Slavica Janeva, MD, Chenyang Zhang, MSc, Anikó Kovács, PhD, Toshima Z Parris, PhD, Jennifer A Crozier, MD, Christopher M Pezzi, MD, Barbro Linderholm, PhD, Riccardo A Audisio, ProfPhD, Roger Olofsson Bagge, PhD
Publikováno v:
The Lancet. Healthy Longevity, Vol 1, Iss 3, Pp e117-e124 (2020)
Summary: Background: Triple-negative breast cancer (TNBC) is an aggressive form of breast cancer associated with poor survival, in which adjuvant systemic treatments are limited to chemotherapy. Due to competing mortality risks and comorbidities, old
Externí odkaz:
https://doaj.org/article/6af47ccba0a947cfa1d847d41dad9238
Autor:
Brian M Necela, Jennifer A Crozier, Cathy A Andorfer, Laura Lewis-Tuffin, Jennifer M Kachergus, Xochiquetzal J Geiger, Krishna R Kalari, Daniel J Serie, Zhifu Sun, Alvaro Moreno-Aspitia, Daniel J O'Shannessy, Julia D Maltzman, Ann E McCullough, Barbara A Pockaj, Heather E Cunliffe, Karla V Ballman, E Aubrey Thompson, Edith A Perez
Publikováno v:
PLoS ONE, Vol 10, Iss 4, p e0127133 (2015)
Externí odkaz:
https://doaj.org/article/f28ac823efda4e2fbe09cc5316b422dd
Autor:
Brian M Necela, Jennifer A Crozier, Cathy A Andorfer, Laura Lewis-Tuffin, Jennifer M Kachergus, Xochiquetzal J Geiger, Krishna R Kalari, Daniel J Serie, Zhifu Sun, Alvaro Moreno-Aspitia, Daniel J O'Shannessy, Julia D Maltzman, Ann E McCullough, Barbara A Pockaj, Heather E Cunliffe, Karla V Ballman, E Aubrey Thompson, Edith A Perez
Publikováno v:
PLoS ONE, Vol 10, Iss 3, p e0122209 (2015)
Folate receptor alpha (FOLR1) has been identified as a potential prognostic and therapeutic target in a number of cancers. A correlation has been shown between intense overexpression of FOLR1 in breast tumors and poor prognosis, yet there is limited
Externí odkaz:
https://doaj.org/article/ba6ccd31d0af49ebb6c31344775b5f0a
Autor:
Dipali Sharma, William Audeh, Raquel Nunes, Sahra Uygun, Mehran Habibi, Lisa Blumencranz, Heather M. Kling, Jennifer A. Crozier, Sarah Untch
Publikováno v:
Cancer Research. 81:PS7-68
Background: African American breast cancer patients (AA) are diagnosed at a younger age and present more frequently with triple-negative/Basal tumors than Caucasian American patients (CA). High prevalence of obesity, type 2 diabetes mellitus (T2DM),
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::14d8f9e29e55e1f496c0db237965560a
https://doi.org/10.1158/1538-7445.sabcs20-ps7-68
https://doi.org/10.1158/1538-7445.sabcs20-ps7-68
Autor:
Jennifer A. Crozier, Caitlin Hodge, Beth-Ann Lesnikoski, Laila Samiian, Todd A. Pezzi, Christopher M. Pezzi, William A. Hammond, Riccardo A. Audisio, Slavica Janeva, Amanda Devereaux
Publikováno v:
The Lancet Oncology. 21:1611-1619
There is a scarcity of data exploring the benefits of adjuvant or neoadjuvant chemotherapy in the treatment of breast cancer in older women. We aimed to explore the effect of adding chemotherapy to local therapy on overall survival in older women wit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f9250aa2c3b234779bddc8fc5672ae6a
https://doi.org/10.1016/s1470-2045(20)30538-6
https://doi.org/10.1016/s1470-2045(20)30538-6
Autor:
Caitlin Hodge, Amanda Shreders, Todd A. Pezzi, William A. Hammond, Laila Samiian, Beth-Ann Lesnikoski, Jennifer A. Crozier, Riccardo A. Audisio, Christopher M. Pezzi
Publikováno v:
Cancer Research. 80:P2-14
Purpose: The benefit of chemotherapy in older women with breast cancer is not well defined. The aim of this study was to explore the effect of chemotherapy on overall survival (OS) in women ≥ 70 years old with triple-negative breast cancer (TNBC) u
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6cf08ca5efc38471140f9ec1a5e258cd
https://doi.org/10.1158/1538-7445.sabcs19-p2-14-03
https://doi.org/10.1158/1538-7445.sabcs19-p2-14-03
Autor:
Mehran Habibi, Nina D'Abreo, Adam Brufsky, William Audeh, Pat Whitworth, Gordan Srkalovic, Ian Grady, Erin Yoder, Bastiaan van der Baan, Thomas Lomis, Jennifer A. Crozier, Heather M. Kling, Charles E. Cox, Sarah Untch
Publikováno v:
Cancer Research. 80:OT3-17
Background discussion: Genomic signatures are revolutionizing the definition, identification, and treatment of breast cancer. To precisely stratify breast cancers into actionable subgroups, full genome (FG) expression data and matching clinical data
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::caba9080f1827d0fc2e97c252b465ba9
https://doi.org/10.1158/1538-7445.sabcs19-ot3-17-02
https://doi.org/10.1158/1538-7445.sabcs19-ot3-17-02
Autor:
Raquel Nunes, William Audeh, Sahra Uygun, Erin Yoder, Sarah Untch, Lisa Blumencranz, Heather M. Kling, Jennifer A. Crozier
Publikováno v:
Cancer Research. 80:P2-10
Background: Breast cancer (BC) mortality is higher in African-American women (AA) than in Caucasian women (CA). AA are also diagnosed at a younger age, have more aggressive subtypes and greater incidence of metabolic dysfunction such as obesity and d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9db19be097b5393ff5162c7fdc4d33d2
https://doi.org/10.1158/1538-7445.sabcs19-p2-10-08
https://doi.org/10.1158/1538-7445.sabcs19-p2-10-08
Autor:
Jennifer A. Crozier, Julie Barone, Pat Whitworth, Abraham Cheong, Robert Maganini, Jose Perez Tamayo, Patricia Dauer, Shiyu Wang, William Audeh, Annuska M. Glas
Publikováno v:
Journal of surgical oncology. 125(4)
With increased neoadjuvant therapy recommendations for early-stage breast cancer patients due to the COVID-19 pandemic, it is imperative that molecular diagnostic assays provide reliable results from preoperative core needle biopsies (CNB). The study
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::376f5e4de99dcb5161715e430db51127
https://pubmed.ncbi.nlm.nih.gov/34964996
https://pubmed.ncbi.nlm.nih.gov/34964996
Autor:
Barone J, Shiyu Wang, Mee S, Andrea Menicucci, Cheong A, Yang S, C. Finn, P Whitworth, Anke T. Witteveen, Corcoran K, Dauer P, Huynh Y, Jennifer A. Crozier, Erin Yoder, Jennifer Wei, Tran A, van der Baan B, Maganini R, Christa Dreezen, William Audeh, Annuska M. Glas, Ruby J, Falk J
IntroductionWith an increase in neoadjuvant therapy recommendations for most early-stage breast cancer patients due to the COVID-19 pandemic, it has become increasingly imperative to ensure that molecular diagnostic assays provide reliable results fr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a2dd6b7267ebd8c7487f973061c5b646
https://doi.org/10.1101/2021.05.28.21257887
https://doi.org/10.1101/2021.05.28.21257887
